Abstract
BackgroundInfluenza neuraminidase (NA) is essential for virus release from its host cells and it is one of the targets for structure-based antiviral drug design.ResultsIn this report, we established a pseudoviral particle release assay to study NA function, which is based on lentiviral particles pseudotyped with influenza glycoproteins HA and NA as a surrogate system. Through an extensive molecular analysis, we sought to characterize important residues governing NA function. We identified five residues of NA, 234, 241, 257, 286 and 345, four of which (except 345) map away from the active site of NA when projected onto the three-dimensional structure of avian influenza H5N1 NA, and substitutions of these residues adversely affected the NA-mediated viral particle release, suggesting that these residues are critical for NA enzymatic activity.ConclusionThrough extensive chimeric and mutational analyses, we have identified several residues, which map away from the active site and are critical for NA function. These findings provide new insights into NA-mediated pseudoviral particle release and may have important implications in drug design and therapeutics against influenza infection.
Highlights
Influenza neuraminidase (NA) is essential for virus release from its host cells and it is one of the targets for structure-based antiviral drug design
These findings provide new insights into NA-mediated pseudoviral particle release and may have important implications in drug design and therapeutics against influenza infection
These results correlate with the luciferase data, further suggesting that NA from an avian H5N1 virus (NAA) is deficient in mediating pseudovirion release from the 293T producer cell surface
Summary
Influenza neuraminidase (NA) is essential for virus release from its host cells and it is one of the targets for structure-based antiviral drug design. HA binds N-acetyl neuraminic acid (Neu5Ac) mediating virus entry, whereas NA catalyzes Neu5Ac receptor removal facilitating viral particle release. NA is one example where an enveloped virus has evolved a mechanism to promote influenza virus release, Several other roles have been proposed for NA including (1) clearance of ‘decoy’ receptors within the respiratory mucin [11], (2) reduction of viral superinfection [12], and (3) enhancement of viral infectivity [13,14]. It is interesting to note that, in the absence of efficient NA activity, progeny virions aggregate at the cell surface; a release-competent mutant lacking the NA active site was the result of decreased HA binding to Neu5Ac receptors. There appears to exist a balance of NA and HA activities in orchestrating viral particle release [16,17,18]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.